1. Home
  2. MNKD vs PDFS Comparison

MNKD vs PDFS Comparison

Compare MNKD & PDFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • PDFS
  • Stock Information
  • Founded
  • MNKD 1991
  • PDFS 1992
  • Country
  • MNKD United States
  • PDFS United States
  • Employees
  • MNKD N/A
  • PDFS N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • PDFS EDP Services
  • Sector
  • MNKD Health Care
  • PDFS Technology
  • Exchange
  • MNKD Nasdaq
  • PDFS Nasdaq
  • Market Cap
  • MNKD 1.1B
  • PDFS 930.3M
  • IPO Year
  • MNKD 2004
  • PDFS N/A
  • Fundamental
  • Price
  • MNKD $4.06
  • PDFS $23.79
  • Analyst Decision
  • MNKD Buy
  • PDFS Strong Buy
  • Analyst Count
  • MNKD 6
  • PDFS 3
  • Target Price
  • MNKD $9.33
  • PDFS $33.33
  • AVG Volume (30 Days)
  • MNKD 3.0M
  • PDFS 297.7K
  • Earning Date
  • MNKD 08-06-2025
  • PDFS 08-07-2025
  • Dividend Yield
  • MNKD N/A
  • PDFS N/A
  • EPS Growth
  • MNKD 228.27
  • PDFS N/A
  • EPS
  • MNKD 0.10
  • PDFS 0.03
  • Revenue
  • MNKD $297,595,000.00
  • PDFS $185,933,000.00
  • Revenue This Year
  • MNKD $13.72
  • PDFS $23.39
  • Revenue Next Year
  • MNKD $14.94
  • PDFS $18.37
  • P/E Ratio
  • MNKD $39.14
  • PDFS $656.65
  • Revenue Growth
  • MNKD 32.50
  • PDFS 11.75
  • 52 Week Low
  • MNKD $3.51
  • PDFS $15.91
  • 52 Week High
  • MNKD $7.63
  • PDFS $36.25
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 55.84
  • PDFS 65.64
  • Support Level
  • MNKD $3.74
  • PDFS $23.09
  • Resistance Level
  • MNKD $4.13
  • PDFS $23.92
  • Average True Range (ATR)
  • MNKD 0.14
  • PDFS 0.79
  • MACD
  • MNKD 0.05
  • PDFS -0.05
  • Stochastic Oscillator
  • MNKD 88.14
  • PDFS 82.14

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About PDFS PDF Solutions Inc.

PDF Solutions Inc offers products and services designed to empower engineers and data scientists across the semiconductor ecosystem to improve the yield, quality, and profitability of their products. The solutions combine proprietary software, physical intellectual property (or IP) for integrated circuit (or IC) designs, electrical measurement hardware tools, various methodologies, and professional services. The company's products and services are sold to integrated device manufacturers (or IDMs), fabless semiconductor companies, foundries, outsourced semiconductor assembly and test (or OSATs), and system houses.

Share on Social Networks: